Conversion to Belatacept in kidney transplant recipients with chronic antibody-mediated rejection (CAMR)

Moein, M; Gao, SQX; Martin, SJ; Farkouh, KM; Li, BW; Ball, AS; Dvorai, RH; Saidi, RF

Saidi, RF (通讯作者),SUNY Upstate Med Univ, Dept Surg, Div Transplant Serv, 750 East Adams St, Syracuse, NY 13210 USA.

TRANSPLANT IMMUNOLOGY, 2023; 76 ():

Abstract

Background: The costimulatory inhibitor Belatacept (Bela) has been shown to be an effective alternative in several clinical situations, including chro......

Full Text Link